Search Results for "Cancer Diagnostics"
Original Source: Lab21 Launches New Lung Cancer Diagnostic Service
Cambridge, UK – 16 February 2012 - Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics has launched a new Companion Diagnostic testing service for non-small cell lung cancer patients. The EML4-ALK companion diagnostic test for translocations in the ALK gene will allow physicians to select lung cancer patients likely to respond to ALK inhibitor therapy. The test uses proprietary PCR technology and will be performed in Lab21’s accredited laboratories in...
Matching Channels
Diagnostics - news, views, blogs
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease...
Roche is the 5th largest pharmaceutical company in the world, based on annual sales, which were recorded at $36,017m in 2009. The pharmaceutical products of Roche are major players in the followin...
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain...
Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. Symptoms include vaginal bleeding, but may not present until later stages of the cancer. Cervical cancer can be treated...
BioPortfolio has created a number of Twitter accounts to help you keep upto date on the latest news, research papers, reports and clinical trials on a selected range of important and popular topics....
Matching News
Matrix-Bio, Quest Diagnostics enter global licensing agreement for metabolomic biomarkers
Matrix-Bio, Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive global licensing and marketing agreement for metabolomic biomarkers...
Diagnostics maker to release thyroid cancer assay
Quest Diagnostics will launch its Thyroid Cancer Mutation Panel designed to identify genetic mutations associated with papill -More-
Advanced Cell raises $12M in series B
Advanced Cell Diagnostics Inc. (Hayward, Calif.) raised $12 million in a series B round led by new investor New Leaf Venture Partners. Existing investor Morningside Ventures also participated. Advance...
Roche, AZN in companion diagnostics deal
AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered with Roche Diagnostics to develop companion diagnostics for undisclosed products from AstraZeneca and its MedImmune LLC biologics unit. AstraZeneca said t...
Agilent moves into companion diagnostics with $2.2 billion Dako buy
Bio-analytical measurement specialist Agilent Technologies has agreed to acquire Danish tissue-based cancer diagnostics firm Dako for $2.2 billion, strengthening its presence in the molecular diagno...
[Roche Diagnostics] to develop companion tests for drugs in development at [AZ]/[MedImmune]
[Roche Diagnostics Corp.] and its contingency of diagnostics business units have agreed to design companion tests that [AstraZeneca PLC] and its [MedImmune LLC] division will use in their drug develop...
Merck grants HTG Molecular Diagnostics its rights to breast cancer markers
HTG Molecular Diagnostics has been granted a non-exclusive license to develop, manufacture, and commercialize breast cancer diagnostic tests under Merck’s patent portfolio. The Netherlands Cance...
Strand Diagnostics, Inc.: Series A $30M
Strand Diagnostics (Indianapolis, IN) a commercial-stage molecular diagnostics company focused on DNA screening of breast and prostate biopsy samples and patient DNA for molecular cancer diagnosis ver...
Matching PubMed Articles
Support Vector Machine on Fluorescence Landscapes for Breast Cancer Diagnostics.
Excitation-emission matrices (EEM) and total synchronous fluorescence spectra (SFS) of normal and malignant breast tissue specimens are measured in UV-VIS spectral region to serve as data inputs in de...
Cancer detection using nanoparticle-based sensors.
This tutorial review surveys the latest achievements in the use of nanoparticles to detect cancer biomarkers and cancer cells with a focus on optical and electrochemical techniques. Nanoparticle based...
Circulating tumor cell isolation and diagnostics: toward routine clinical use.
From February 7-11, 2011, the multidisciplinary Lorentz Workshop Circulating Tumor Cell (CTC) Isolation and Diagnostics: Toward Routine Clinical Use was held in Leiden (The Netherlands) to discuss pro...
